TOP特許意匠商標
商標ウォッチ Twitter
公開日2024-10-09
公報種別公開国際商標公報
国際登録番号1803794
国際登録日2024-05-02
区分第5類(薬剤)
商品役務Pharmaceutical preparations for the treatment of brain disease using technology capable of passing through the blood-brain barrier (BBB) to deliver therapeutic proteins directly to brain tissue, using the DAT (dual action therapy) platform for medical purposes; pharmaceutical preparations for the treatment of Alzheimer’s disease (senile dementia); pharmaceutical preparations for the treatment of brain disease for medical purposes; pharmaceutical preparations for the treatment of central nervous system [CNS] diseases; pharmaceutical preparations for the treatment of neurodegenerative brain diseases for medical purposes; pharmaceutical preparations for the treatment of Parkinson’s disease.
基礎出願番号
基礎出願日
基礎出願国
出願人L&J Bio Co.,Ltd.
OCRテキストLNJ
OCRテキスト2LNJ
OCRについて
この商標をJ-PlatPatで参照する

関連商標

L&J Bio Co.,Ltd.
LNJ
7か月前
NUTRITIONAL WHOLESOME BLENDS PTY LTD
Blended. BYSARAH
1か月前
Biohaven Therapeutics Ltd.
1か月前
Aston Group Worldwide Ltd
INESSA
23日前
Made By Brave Limited
ANCIENT+BRAVE
23日前
Biohaven Therapeutics Ltd.
REJUTRIA
1か月前
Harbin Fuerjia Technology Co., Ltd.
Voolga
23日前
MAFRA GROUP S.r.l.
MANIAC LINE
23日前
SANOFI PASTEUR
1か月前
SANOFI PASTEUR
1か月前
SANOFI PASTEUR
1か月前
SANOFI PASTEUR
1か月前
JW PHARMACEUTICAL CORPORATION
1か月前
JW PHARMACEUTICAL CORPORATION
1か月前
SANOFI PASTEUR
1か月前
ZHEJIANG BAIXING FOOD CO., LTD.
1か月前
JW PHARMACEUTICAL CORPORATION
1か月前
Shanghai Bao Pharmaceuticals Co., Ltd.
1か月前
LabSpinner Inc.
1か月前
SANOFI PASTEUR
1か月前
2SAN Global Limited
1か月前
Upfield Europe B.V.
1か月前
JW PHARMACEUTICAL CORPORATION
1か月前
SANOFI PASTEUR
1か月前
Constellation Pharmaceuticals, Inc.
1か月前
Dyne Therapeutics, Inc.
1か月前
BioGaia AB
1か月前
AAVantgarde Bio Srl
1か月前
MERCK Kommanditgesellschaft auf Aktien
1か月前
MERCK Kommanditgesellschaft auf Aktien
1か月前
MERCK Kommanditgesellschaft auf Aktien
1か月前
Merck Kommanditgesellschaft auf Aktien
1か月前
Monte Rosa Therapeutics AG
1か月前
BioGaia AB
1か月前
Astria Therapeutics, Inc.
1か月前
Wuxi Biologics (Shanghai) Co., Ltd.
1か月前
続きを見る